Publication: Hepatitis B and Measles Seroprevalence Among Turkish Children
| dc.authorscopusid | 7004528527 | |
| dc.authorscopusid | 7003829656 | |
| dc.authorscopusid | 7003836321 | |
| dc.authorscopusid | 7003387214 | |
| dc.authorscopusid | 7003363965 | |
| dc.authorscopusid | 7004380255 | |
| dc.authorscopusid | 36979374200 | |
| dc.contributor.author | Kanra, G. | |
| dc.contributor.author | Tezcan, S. | |
| dc.contributor.author | Badur, S. | |
| dc.contributor.author | Alp, H. | |
| dc.contributor.author | Bulut, A. | |
| dc.contributor.author | Cin, S. | |
| dc.contributor.author | Mocan, G. | |
| dc.date.accessioned | 2020-06-21T09:23:37Z | |
| dc.date.available | 2020-06-21T09:23:37Z | |
| dc.date.issued | 2005 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Kanra] Güler Y., Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey; [Tezcan] Sabahat, Department of Public Health, Hacettepe Üniversitesi, Ankara, Turkey; [Badur] Selim, Department of Microbiology, İstanbul Tıp Fakültesi, Istanbul, Turkey; [Alp] Handan, Department of Pediatrics, Ataturk University, Faculty of Medicine, Erzurum, Turkey; [Bulut] Ayşen, Department of Pediatrics, Istanbul Üniversitesi, Istanbul, Turkey; [Cin] Şükrü, Department of Pediatrics, Ankara Üniversitesi, Ankara, Turkey; [Mocan] Gamze, Department of Pediatrics, Karadeniz Technical University, Trabzon, Trabzon, Turkey; [Dağbaşı] Nükhet, GlaxoSmithKline plc., Brentford, Middlesex, United Kingdom; [Dundar] C., Department of Pediatrics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Egemen] Ayten, Department of Pediatrics, Ege Üniversitesi, Izmir, Turkey; [Eskiocak] Muzaffer, Department of Pediatrics, Trakya Üniversitesi, Edirne, Edirne, Turkey; [Evliyaog̀lu] Nurdan, Department of Pediatrics, Çukurova Üniversitesi, Adana, Adana, Turkey; [Güraksin] Aytaç, Department of Pediatrics, Ataturk University, Faculty of Medicine, Erzurum, Turkey; [Kara] Ateş, Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey; [Mocan] Hilal, Department of Pediatrics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Ozmert] Elif N., Department of Pediatrics, Hacettepe Üniversitesi, Ankara, Turkey; [Öztürk] Fadil, Department of Pediatrics, Karadeniz Technical University, Trabzon, Trabzon, Turkey; [Saka] Gunay, Department of Pediatrics, Dicle Üniversitesi, Diyarbakir, Diyarbakir, Turkey; [Sıdal] Müjgan, Department of Pediatrics, Istanbul Üniversitesi, Istanbul, Turkey; [Ulukol] B., Department of Pediatrics, Ankara Üniversitesi, Ankara, Turkey; [Tanyer] Gülten, Department of Pediatrics, Ankara Numune Hospital, Ankara, Turkey; [Taş] Mehmet Ali, Department of Pediatrics, Dicle Üniversitesi, Diyarbakir, Diyarbakir, Turkey; [Velicangil] Ömer, GlaxoSmithKline plc., Brentford, Middlesex, United Kingdom; [Yazicioĝlu] Mehtap, Department of Pediatrics, Trakya Üniversitesi, Edirne, Edirne, Turkey | en_US |
| dc.description.abstract | This study was performed to determine hepatitis B and measles seroprevalence among the population under 30 years of age in Turkey. Blood samples of 2,683 subjects from eight provinces of Turkey were studied. Measles IgG was determined by hemagglutinin inhibition method, and hepatitits B surface antigen (HBsAg), anti-hepatitis B surface antibody (anti-HBs) and anti-hepatitis B core antibodies (anti-HBc) were determined by ELISA method. Overall seropositivity for measles was found to be 59.6%. There was a significant difference in seropositivity among provinces. The seropositivity was found to increase with age. The overall seropositivities for HBsAg, anti-HBs and anti-HBc were found to be 5.4%, 17% and 15.1 %, respectively. The seroprevalences differed significantly among provinces. Although seroprevalence for anti-HBs and anti-HBc increased with age, HBsAg seropositivity did not change significantly after one year of age. Seroprevalence was not affected by sex. It was concluded that every effort should be given to vaccinate infants as early as possible for hepatitis B and that the coverage of infancy measles vaccination should be increased with a second dose. | en_US |
| dc.identifier.endpage | 110 | en_US |
| dc.identifier.issn | 0041-4301 | |
| dc.identifier.issn | 2791-6421 | |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.pmid | 16052847 | |
| dc.identifier.scopus | 2-s2.0-20144371839 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 105 | en_US |
| dc.identifier.volume | 47 | en_US |
| dc.identifier.wosquality | Q3 | |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | Turkish Journal of Pediatrics | en_US |
| dc.relation.journal | Turkish Journal of Pediatrics | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Hepatitis B | en_US |
| dc.subject | Measles | en_US |
| dc.subject | Seroprevalence | en_US |
| dc.title | Hepatitis B and Measles Seroprevalence Among Turkish Children | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
